相关实验视频

Updated: Jun 30, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K

在的分子对接和在体外分析的atomoxetine

Nurullah Bolat1, Merve Meliha Hız-Çelikliyurt2, Erhan Akıncı3

  • 1Faculty of Medicine, Department of Child and Adolescent Psychiatry, Çanakkale Onsekiz Mart University, Çanakkale, Türkiye.

Drug and chemical toxicology
|January 28, 2025
PubMed
概括

用于ADHD的阿托莫克赛丁在体外治疗剂量时没有表现出基因毒性作用. 然而,较高剂量诱导了基因毒性,在中没有发现显著的DNA结合.

关键词:
阿托莫克西丁 (Atomoxetine) 是一种药物.注意力缺陷是一个问题.细胞毒性 细胞毒性遗传毒性 遗传毒性 遗传毒性过度活跃症是一种过度活跃的症状.分子对接的分子对接.

更多相关视频

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.3K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

334

相关概念视频

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...